Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • ImmunoCellular soars on hope for ICT-107 [View news story]
    I'll be childish also, " Booooyah from Oregon.
    BUY more IMUC while you can at this price !
    What a NO - BRAINER.
    Everyone knows someone who has died unfortunately and
    prematurely from this DEADLY CANCER of the BRAIN.
    Oh My !!
    Nov 25, 2013. 06:06 PM | 1 Like Like |Link to Comment
  • Ignore the slowdown in China at your own peril, writes Ben Levisohn after GDP growth slipped to 7.5% in Q2, and Beijing shows little sign of easing policy to re-boost it. Consumer staples and health care stocks with high China exposure like Mead Johnson (MJN) and PerkinElmer (PKI) have recently underperformed (on a relative basis), but also at risk are those in materials, industrials, and IT with a heavy reliance on China: DOW, ALTR, EXPD, GE. On the other hand there's Las Vegas Sands (LVS) - maybe unfairly (relatively) punished for its Macau exposure even as the secular growth of gambling there should offset any cyclical economic weakness in China. [View news story]
    Why is the price of LVS so range bound considering the following
    facts: ???
    - most countries would love to have a 7%+ annual growth rate.
    - any business in the world has to envy the y/o/y increases in
    business activity enjoyed by Macau and all gambling/leisure
    ventures there. That's exactly how they have 'trumped' Las
    - Asians do have a propensity for gambling and as the middle
    class in China and the rest of Asia grows, ' Las Vegas ' type
    pleasures will surely be enjoyed by a larger slice of the pop-
    ulations in the East, not just the 'high rollers'.
    - The new train system linking Macau with the Northern part
    of China will definitely get the 'middle class' to the gaming
    tables much closer to home.
    So, given these facts, why is the price of LVS going nowhere in
    the face of $67-69 analysts price targets?
    Can it be that some potential new LVS investors may be
    put off by the volatility of its' stock price' ? As one can easily see,
    LVS is heavily day- traded. Definitely a good way to make some
    income while waiting for the 'Real Move' upward !
    What do you make of this paradox??!! When will we see $60
    AGAIN ?
    Jul 21, 2013. 11:24 AM | Likes Like |Link to Comment
  • Sterne Agee warns revenue in Macau may only grow 1% in February instead of the double-digit pace expected by some analysts, although its keeps a positive stance on the Macau gaming sector for the long term. A crackdown on the VIP segment may only be a blip on the radar, according to the firm. Gaming companies with ties to the region are down premarket as initial reports on Chinese New Year gaming activity are disappointing. MPEL -2.2%, WYNN -1.8%, LVS -2.2%[View news story]
    Most companies would "die" to have the y/y increases in revenue that LVS recently reported and continue to realize !! Didn't they report a
    48% increase in yearly earnings. What about the money LVS earns
    operating their casino in Singapore ? And the high-speed train from
    Beijing that will now bring middle income Chinese to Macau to both
    recreate and gamble. Are these facts not relevant or am I missing
    something here ? I too am frustrated with the stagnant performance
    of the LVS share price in the midst of such facts and positive ratings!!
    Feb 20, 2013. 08:56 AM | 1 Like Like |Link to Comment
  • Nomura weighs in on the fickle Macau gaming market, reporting month-to-date revenue is up an encouraging 15% Y/Y through December 16. The firm thinks a double-digit pace of VIP revenue growth could provide a psychological lift to Macau-related gaming firms such as Las Vegas Sands (LVS +0.2%), Wynn Resorts (WYNN +0.4%), and MGM Resorts. [View news story]
    Burch1"s Comments are spot on. All the government has to do
    is open up Macau to the Chinese mass market and watch the
    y/o/y revenues soar ! Asians will gamble on ANYTHING !
    Dec 19, 2012. 01:46 PM | Likes Like |Link to Comment